AST Insider Trading Activity and SEC Form 4 Filings
AST insider trading summary
No open-market insider purchases or sales of Asterias Biotherapeutics, Inc. (AST) have been reported on SEC Form 4 in the past 12 months.
Latest AST insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 27, 2018 | Michael H. Mulroy | President and CEO | Buy | $5K (3,141 @ $1.59) |
| Jul 25, 2018 | Michael H. Mulroy | President and CEO | Buy | $5K (2,950 @ $1.69) |
| Jun 25, 2018 | Michael H. Mulroy | President and CEO | Buy | $5K (3,067 @ $1.63) |
| May 25, 2018 | Michael H. Mulroy | President and CEO | Buy | $5K (3,153 @ $1.59) |
| Apr 25, 2018 | Michael H. Mulroy | President and CEO | Buy | $5K (3,752 @ $1.33) |
| Mar 26, 2018 | Michael H. Mulroy | President and CEO | Buy | $5K (2,839 @ $1.76) |
| Feb 26, 2018 | Michael H. Mulroy | President and CEO | Buy | $5K (2,255 @ $2.22) |
| Jan 25, 2018 | Michael H. Mulroy | President and CEO | Buy | $5K (2,134 @ $2.34) |
| Dec 26, 2017 | Michael H. Mulroy | President and CEO | Buy | $5K (2,247 @ $2.22) |
| Nov 27, 2017 | Michael H. Mulroy | President and CEO | Buy | $5K (2,076 @ $2.41) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.